Cargando…

Impaired Right and Left Ventricular Longitudinal Function in Patients with Fibrotic Interstitial Lung Diseases

Background: Left ventricular (LV) and right ventricular (RV) dysfunction is recognized in idiopathic pulmonary fibrosis (IPF). Little is known about cardiac involvement in non-idiopathic pulmonary fibrosis (no-IPF). This issue can be explored by advanced echocardiography. Methods: Thirty-three clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Buonauro, Agostino, Santoro, Ciro, Galderisi, Maurizio, Canora, Angelo, Sorrentino, Regina, Esposito, Roberta, Lembo, Maria, Canonico, Mario Enrico, Ilardi, Federica, Fazio, Valeria, Golia, Bruno, Sanduzzi Zamparelli, Alessandro, Bocchino, Maria Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073641/
https://www.ncbi.nlm.nih.gov/pubmed/32098133
http://dx.doi.org/10.3390/jcm9020587
_version_ 1783506665039986688
author Buonauro, Agostino
Santoro, Ciro
Galderisi, Maurizio
Canora, Angelo
Sorrentino, Regina
Esposito, Roberta
Lembo, Maria
Canonico, Mario Enrico
Ilardi, Federica
Fazio, Valeria
Golia, Bruno
Sanduzzi Zamparelli, Alessandro
Bocchino, Maria Luisa
author_facet Buonauro, Agostino
Santoro, Ciro
Galderisi, Maurizio
Canora, Angelo
Sorrentino, Regina
Esposito, Roberta
Lembo, Maria
Canonico, Mario Enrico
Ilardi, Federica
Fazio, Valeria
Golia, Bruno
Sanduzzi Zamparelli, Alessandro
Bocchino, Maria Luisa
author_sort Buonauro, Agostino
collection PubMed
description Background: Left ventricular (LV) and right ventricular (RV) dysfunction is recognized in idiopathic pulmonary fibrosis (IPF). Little is known about cardiac involvement in non-idiopathic pulmonary fibrosis (no-IPF). This issue can be explored by advanced echocardiography. Methods: Thirty-three clinically stable and therapy-naive fibrotic IPF and 28 no-IPF patients, and 30 healthy controls were enrolled. Exclusion criteria were autoimmune systemic diseases, coronary disease, heart failure, primary cardiomyopathies, chronic obstructive lung diseases, pulmonary embolism, primary pulmonary hypertension. Lung damage was evaluated by diffusion capacity for carbon monoxide (DLCO(sb)). All participants underwent an echo-Doppler exam including 2D global longitudinal strain (GLS) of both ventricles and 3D echocardiographic RV ejection fraction (RVEF). Results: We observed LV diastolic dysfunction in IPF and no-IPF, and LV GLS but not LV EF reduction only in IPF. RV diastolic and RV GLS abnormalities were observed in IPF versus both controls and no-IPF. RV EF did not differ significantly between IPF and no-IPF. DLCO(sb) and RV GLS were associated in the pooled pulmonary fibrosis population and in the IPF subgroup (β = 0.708, p < 0.001), independently of confounders including pulmonary arterial systolic pressure. Conclusion: Our data highlight the unique diagnostic capabilities of GLS in distinguishing early cardiac damage of IPF from no-IPF patients.
format Online
Article
Text
id pubmed-7073641
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70736412020-03-19 Impaired Right and Left Ventricular Longitudinal Function in Patients with Fibrotic Interstitial Lung Diseases Buonauro, Agostino Santoro, Ciro Galderisi, Maurizio Canora, Angelo Sorrentino, Regina Esposito, Roberta Lembo, Maria Canonico, Mario Enrico Ilardi, Federica Fazio, Valeria Golia, Bruno Sanduzzi Zamparelli, Alessandro Bocchino, Maria Luisa J Clin Med Article Background: Left ventricular (LV) and right ventricular (RV) dysfunction is recognized in idiopathic pulmonary fibrosis (IPF). Little is known about cardiac involvement in non-idiopathic pulmonary fibrosis (no-IPF). This issue can be explored by advanced echocardiography. Methods: Thirty-three clinically stable and therapy-naive fibrotic IPF and 28 no-IPF patients, and 30 healthy controls were enrolled. Exclusion criteria were autoimmune systemic diseases, coronary disease, heart failure, primary cardiomyopathies, chronic obstructive lung diseases, pulmonary embolism, primary pulmonary hypertension. Lung damage was evaluated by diffusion capacity for carbon monoxide (DLCO(sb)). All participants underwent an echo-Doppler exam including 2D global longitudinal strain (GLS) of both ventricles and 3D echocardiographic RV ejection fraction (RVEF). Results: We observed LV diastolic dysfunction in IPF and no-IPF, and LV GLS but not LV EF reduction only in IPF. RV diastolic and RV GLS abnormalities were observed in IPF versus both controls and no-IPF. RV EF did not differ significantly between IPF and no-IPF. DLCO(sb) and RV GLS were associated in the pooled pulmonary fibrosis population and in the IPF subgroup (β = 0.708, p < 0.001), independently of confounders including pulmonary arterial systolic pressure. Conclusion: Our data highlight the unique diagnostic capabilities of GLS in distinguishing early cardiac damage of IPF from no-IPF patients. MDPI 2020-02-21 /pmc/articles/PMC7073641/ /pubmed/32098133 http://dx.doi.org/10.3390/jcm9020587 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Buonauro, Agostino
Santoro, Ciro
Galderisi, Maurizio
Canora, Angelo
Sorrentino, Regina
Esposito, Roberta
Lembo, Maria
Canonico, Mario Enrico
Ilardi, Federica
Fazio, Valeria
Golia, Bruno
Sanduzzi Zamparelli, Alessandro
Bocchino, Maria Luisa
Impaired Right and Left Ventricular Longitudinal Function in Patients with Fibrotic Interstitial Lung Diseases
title Impaired Right and Left Ventricular Longitudinal Function in Patients with Fibrotic Interstitial Lung Diseases
title_full Impaired Right and Left Ventricular Longitudinal Function in Patients with Fibrotic Interstitial Lung Diseases
title_fullStr Impaired Right and Left Ventricular Longitudinal Function in Patients with Fibrotic Interstitial Lung Diseases
title_full_unstemmed Impaired Right and Left Ventricular Longitudinal Function in Patients with Fibrotic Interstitial Lung Diseases
title_short Impaired Right and Left Ventricular Longitudinal Function in Patients with Fibrotic Interstitial Lung Diseases
title_sort impaired right and left ventricular longitudinal function in patients with fibrotic interstitial lung diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073641/
https://www.ncbi.nlm.nih.gov/pubmed/32098133
http://dx.doi.org/10.3390/jcm9020587
work_keys_str_mv AT buonauroagostino impairedrightandleftventricularlongitudinalfunctioninpatientswithfibroticinterstitiallungdiseases
AT santorociro impairedrightandleftventricularlongitudinalfunctioninpatientswithfibroticinterstitiallungdiseases
AT galderisimaurizio impairedrightandleftventricularlongitudinalfunctioninpatientswithfibroticinterstitiallungdiseases
AT canoraangelo impairedrightandleftventricularlongitudinalfunctioninpatientswithfibroticinterstitiallungdiseases
AT sorrentinoregina impairedrightandleftventricularlongitudinalfunctioninpatientswithfibroticinterstitiallungdiseases
AT espositoroberta impairedrightandleftventricularlongitudinalfunctioninpatientswithfibroticinterstitiallungdiseases
AT lembomaria impairedrightandleftventricularlongitudinalfunctioninpatientswithfibroticinterstitiallungdiseases
AT canonicomarioenrico impairedrightandleftventricularlongitudinalfunctioninpatientswithfibroticinterstitiallungdiseases
AT ilardifederica impairedrightandleftventricularlongitudinalfunctioninpatientswithfibroticinterstitiallungdiseases
AT faziovaleria impairedrightandleftventricularlongitudinalfunctioninpatientswithfibroticinterstitiallungdiseases
AT goliabruno impairedrightandleftventricularlongitudinalfunctioninpatientswithfibroticinterstitiallungdiseases
AT sanduzzizamparellialessandro impairedrightandleftventricularlongitudinalfunctioninpatientswithfibroticinterstitiallungdiseases
AT bocchinomarialuisa impairedrightandleftventricularlongitudinalfunctioninpatientswithfibroticinterstitiallungdiseases